Results 251 to 260 of about 1,581,460 (288)

Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors. [PDF]

open access: yesCancers (Basel)
Arnold L   +10 more
europepmc   +1 more source

IL-13 and IL-13-induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis. [PDF]

open access: yesJ Allergy Clin Immunol
Harmon R   +21 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma

Expert Opinion on Biological Therapy, 2013
Asthma markedly diminishes quality of life due to limited activity, absences from work or school and hospitalizations. Patients with severe asthma which are not controlled despite taking effective therapy are most in need of new treatment approaches.
Swati, Agrawal, Robert G, Townley
openaire   +2 more sources

IL-13 Effector Functions

Annual Review of Immunology, 2003
IL-13 was first recognized for its effects on B cells and monocytes, where it upregulated class II expression, promoted IgE class switching and inhibited inflammatory cytokine production. It was also thought to be functionally redundant with IL-4. However, studies conducted with knockout mice, neutralizing antibodies, and novel antagonists demonstrate ...
openaire   +2 more sources

Genetics of IL-13 and functional relevance of IL-13 variants

Current Opinion in Allergy and Clinical Immunology, 2002
Studies in both humans and mice clearly show that interleukin (IL)-13 is a central regulator of allergic inflammation. Numerous single nucleotide polymorphisms have been recently identified in the IL-13 gene and have been found to be associated with allergic and/or asthmatic phenotypes in different populations throughout the world.
openaire   +2 more sources

Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease

Immunological Reviews, 2004
Summary:  Interleukin (IL)‐13 is a key inducer of several type‐2 cytokine‐dependent pathologies. It regulates inflammation, mucus production, tissue remodeling, and fibrosis. Consequently, it has become an important therapeutic target for a number of debilitating illnesses, including asthma, idiopathic pulmonary fibrosis, ulcerative colitis, as well as
Margaret M, Mentink-Kane, Thomas A, Wynn
openaire   +2 more sources

Home - About - Disclaimer - Privacy